Radioimmunotherapy of interleukin-2Rα-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac

Blood

Volumn 86, Issue 11, 1995, Pages 4063-4075

  Waldmann, T A ^a   White, J D ^a   Carrasquillo, J A ^a   Reynolds, J C ^a   Paik, C H ^a   Gansow, O A ^a   Brechbiel, M W ^a   Jaffe, E S ^a   Fleisher, T A ^a   Goldman, C K ^a   Top, L E ^a   Bamford, R ^a   Zaknoen, S ^a   Roessler, E ^a   Kasten Sportes, C ^a   England, R ^a   Litou, H ^a   Johnson, J A ^a   Jackson White, T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DIDANOSINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; FUROSEMIDE; INDIUM 111; INTERLEUKIN 2 RECEPTOR; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISONE; RADIOISOTOPE; SURAMIN; VINCRISTINE; YTTRIUM 90; ZIDOVUDINE;

ADULT; AGED; ARTICLE; BONE MARROW DEPRESSION; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GENE REARRANGEMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; T CELL LEUKEMIA; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0028840870     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.11.4063.bloodjournal86114063     Document Type: Article

References (0)